Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureTajamul H Mir, Rushad D Patell, Jason A. Freed
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
ror
Confidence 99%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Platelet-activating anti-PF4 disorders: an overview
10.1053/j.seminhematol.2022.02.005 · 2022
Monoclonal gammopathy of thrombotic/thrombocytopenic significance
10.1182/blood.2022018797 · 2023
Myeloma therapy for monoclonal gammopathy of thrombotic significance
10.1056/nejmc2406453 · 2024
Diagnostic complexity in monoclonal gammopathy of thrombotic significance
10.1056/nejmc2409428 · 2024
VITT-like monoclonal gammopathy of thrombotic significance
10.1056/nejmoa2415930 · 2025
A prospective, blinded study of a PF4-dependent assay for HIT diagnosis
10.1182/blood.2020008195 · 2021
Temporal aspect of heparin-induced thrombocytopenia
10.1056/nejm200104263441704 · 2001
Most anti-PF4 antibodies in vaccine-induced immune thrombotic thrombocytopenia are transient
10.1182/blood.2021014214 · 2022
Monoclonal gammopathy of clinical significance: a novel concept with therapeutic implications
10.1182/blood-2018-04-839480 · 2018
Monoclonal gammopathy of thrombotic significance
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
openalex
Confidence 95%
datacite
Confidence 0%
10.3390/cancers15020480 · 2023
Platelet-activating anti-PF4 antibodies in MGUS patients with thrombosis [abstract]
10.1182/blood-2024-207999 · 2024
Classification of platelet-activating anti-platelet factor 4 disorders
10.1111/ijlh.14486 · 2025
No additional external references are available.